Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Melatonin 3mg tablets receive licence, Colonis Pharma says

Melatonin 3mg film-coated tablets for jet-lag have been licensed for use in the UK, manufacturer Colonis Pharma has announced.

The immediate-release tablets can be used by adults to "facilitate sleep onset" and improve "quality of sleep", the manufacturer said.

“Prior to this launch, licensed immediate-release melatonin was unavailable. Instead, clinicians have prescribed a variety of unlicensed products,” Colonis said.

The film-coating of the tablets can mask their taste, which may aid patient compliance, Colonis added.

The tablets have an 18-month shelf life, "which reduces the need for the medicine to be replaced regularly", it said.

The NHS price for 30 melatonin 3mg tablets is £65.00.

Melatonin 3mg film-coated tablets are available from all mainline wholesalers, including AAH, Alliance Healthcare and Phoenix Healthcare. For more information, contact Colonis on 01892 739 403 or [email protected]

What jet-lag treatments do you recommend?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel